| Product Code: ETC9560381 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Neuroblastoma Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Neuroblastoma Market - Industry Life Cycle |
3.4 Sweden Neuroblastoma Market - Porter's Five Forces |
3.5 Sweden Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Sweden Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Sweden Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Sweden Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroblastoma cases in Sweden |
4.2.2 Advancements in diagnostic technologies and treatment options |
4.2.3 Government initiatives to improve healthcare infrastructure and access to treatments |
4.3 Market Restraints |
4.3.1 High treatment costs and limited reimbursement policies |
4.3.2 Limited awareness about neuroblastoma among healthcare professionals and the general population |
5 Sweden Neuroblastoma Market Trends |
6 Sweden Neuroblastoma Market, By Types |
6.1 Sweden Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Sweden Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Sweden Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Sweden Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Sweden Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Sweden Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Sweden Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Sweden Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Sweden Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Sweden Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Sweden Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Sweden Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Sweden Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Sweden Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Sweden Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Sweden Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Sweden Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Neuroblastoma Market Import-Export Trade Statistics |
7.1 Sweden Neuroblastoma Market Export to Major Countries |
7.2 Sweden Neuroblastoma Market Imports from Major Countries |
8 Sweden Neuroblastoma Market Key Performance Indicators |
8.1 Survival rate of neuroblastoma patients in Sweden |
8.2 Number of clinical trials and research studies focused on neuroblastoma in Sweden |
8.3 Adoption rate of new treatment modalities for neuroblastoma |
9 Sweden Neuroblastoma Market - Opportunity Assessment |
9.1 Sweden Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Sweden Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Sweden Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Sweden Neuroblastoma Market - Competitive Landscape |
10.1 Sweden Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Sweden Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here